New study tracks how ovarian cancer patients fare on maintenance drug niraparib

NCT ID NCT04295577

First seen May 17, 2026 · Last updated May 24, 2026 · Updated 2 times

Summary

This study followed 388 women with advanced ovarian, fallopian tube, or peritoneal cancer who were taking niraparib as a maintenance treatment to keep their cancer from coming back. Researchers observed how well patients tolerated the drug in everyday clinical practice, without giving any new treatment. The goal was to gather real-world safety and usage data, not to test a new cure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Addenbrookes Hospital

    Cambridge, CB2 0QQ, United Kingdom

  • Barts Health NHS Trust

    London, E1 1FR, United Kingdom

  • Belfast Health & Social Care Trust

    Belfast, BT9 7AB, United Kingdom

  • Morecambe Bay NHS Trust

    Lancaster, United Kingdom

  • Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust

    Northwood, HA6 2RN, United Kingdom

  • Northampton General Hospital NHS Trust

    Northampton, NN1 5BD, United Kingdom

  • Queen's Hospital

    Romford, RM7 0AG, United Kingdom

  • Royal Cornwall Hospitals NHS Trust

    Truro, TR1 3LJ, United Kingdom

  • Royal Marsden NHS Foundation Trust

    Sutton, SM2 5PT, United Kingdom

  • Royal United Hospitals Bath

    Bath, BA1 3NG, United Kingdom

  • St James's University Hospital

    Leeds, LS9 7TF, United Kingdom

  • University Hospital Southampton NHS Foundation Trust

    Southampton, SO16 5YA, United Kingdom

  • University Hospitals Birmingham NHS Foundation Trust

    Birmingham, B15 2TH, United Kingdom

  • University Hospitals Bristol NHS Foundation Trust

    Bristol, BS2 8ED, United Kingdom

  • Velindre Cancer Centre, Velindre University NHS Trust

    Cardiff, CF14 2TL, United Kingdom

Conditions

Explore the condition pages connected to this study.